Abstract
The receptors mediating the contractions to both exogenously applied noradrenaline and electrical field stimulation (EFS) were characterized in horse isolated penile resistance arteries. The alpha 1-adrenoceptor-selective antagonist, prazosin, caused competitive rightward shifts of the contractile concentration-response curves (CRC) to phenylephrine. The alpha 2-antagonist, rauwolscine, also displaced to the right the CRC to the alpha 2-adrenoceptor-selective agonist, BHT 920. EFS (0.3 ms, 20-second trains) caused tetrodotoxin-sensitive frequency-dependent contractions which were enhanced in the presence of NG-nitro-L-arginine (L-NOARG, 3 x 10(-5) M), but not affected by mechanical endothelial cell removal. In experiments performed in the presence of L-NOARG, prazosin inhibited contractions to EFS, while rauwolscine inconsistently enhanced the contractile responses. Exogenously added noradrenaline induced contractions which were not changed in endothelium-denuded arteries, but significantly increased in the presence of L-NOARG. Prazosin inhibited the noradrenaline-induced contractions, while rauwolscine did not change the response to noradrenaline either alone or in the presence of prazosin. In the presence of phentolamine (10(...Continue Reading
Citations
Feb 13, 2001·European Journal of Pharmacology·U SimonsenA C Martinez
Aug 12, 2003·European Journal of Pharmacology·Attila KunUlf Simonsen
Aug 11, 1998·European Journal of Pharmacology·P RecioA García-Sacristán
Aug 2, 2003·Urology·Ana Cristina MartínezSara Benedito
May 30, 1998·British Journal of Pharmacology·D PrietoA García-Sacristán
Jun 28, 2002·British Journal of Pharmacology·Hiroya MizusawaKarl-Erik Andersson
Mar 6, 2015·Expert Opinion on Emerging Drugs·Taylor C PeakWayne J G Hellstrom
Apr 14, 2010·The Journal of Sexual Medicine·Nuria VillalbaUlf Simonsen
Sep 18, 2012·European Journal of Pharmacology·Junjing SuUlf Simonsen
Jan 23, 2010·The Journal of Sexual Medicine·Christian GratzkeChristian G Stief
Jul 28, 2010·Experimental Physiology·Hector ZerpaSimon R Bailey
Aug 26, 2010·British Journal of Pharmacology·Cristina ContrerasDolores Prieto
Nov 18, 2005·Vascular Pharmacology·Ana Cristina MartínezSara Benedito
Nov 21, 2009·Journal of Pharmacological Sciences·Ana Cristina MartínezSara Benedito
Apr 29, 2016·BJU International·Serap GurWayne J G Hellstrom
Oct 30, 2016·Basic & Clinical Pharmacology & Toxicology·Martin GrannUlf Simonsen
Apr 2, 2003·Expert Opinion on Therapeutic Targets·Liming JinR Clinton Webb
Jun 30, 2000·Clinical and Experimental Pharmacology & Physiology·A C MartínezS Benedito
Dec 16, 2000·Journal of Cardiovascular Pharmacology·A C MartinezS Benedito
Feb 3, 2007·Neurourology and Urodynamics·Medardo HernándezLuis M Orensanz
Jul 20, 2007·International Journal of Impotence Research·D Prieto
Apr 30, 2002·International Journal of Impotence Research·A C MartínezS Benedito
Jun 12, 2002·International Journal of Impotence Research·U Simonsen
Apr 2, 2004·International Journal of Impotence Research·P RecioM Hernández
Nov 7, 2006·American Journal of Physiology. Heart and Circulatory Physiology·Nuria VillalbaDolores Prieto
Jan 29, 2008·American Journal of Physiology. Heart and Circulatory Physiology·Nuria VillalbaDolores Prieto
Sep 2, 2011·Pharmacological Reviews·K-E Andersson
Nov 24, 2004·British Journal of Pharmacology·Dolores PrietoMedardo Hernández
Feb 8, 2011·American Journal of Physiology. Heart and Circulatory Physiology·Nuria VillalbaDolores Prieto
Sep 19, 2021·Comparative Biochemistry and Physiology. Toxicology & Pharmacology : CBP·Md Zahorul IslamAtsushi Miyamoto